FEATURED LISTINGS
Tech-2564: Clinical Laboratory in Midwest For Sale – Unique Revenue Model
CLIA, COLA, CAP-accredited clinical lab in Midwest for Sale. Unique Revenue Model, Consistent Revenue, Exceptional EBITDA Margins. Revenue: $3.4M, EBITDA: $1.4M
Tech-2558: Fairly New, Clinical Lab in NJ For Sale – Molecular and NGS Assays
This almost brand new NJ Lab is set up as a high throughput lab for Molecular, Covid, and NGS testing. Revenue (10 months): $2.1M, net $1.7M, Price: $2.75M.
Tech-2557: Fast-Growing Clinical Lab in TX For Sale
Profitable, fast-growing Lab in Texas. Mostly non-covid testing. Revenue / EBITDA: $5.7M/690K (2022); $8.2M/$1M+ (2023).
Tech-2556: Fast-Growing Cannabis Testing Lab in Northwest For Sale
Fast-growing Cannabis Lab in the Northwest with high margins For Sale. EBITDA $1.7M
Tech-2520: Brand New Cannabis Testing Laboratory in MI
Fully Equipped, ISO Certified, almost new Cannabis Testing Lab in MI with State License. Save 12-18 months in setting up and 50% on the cost too. Offered for $995K.
Tech-2545: Free-standing Delta Separation Extraction Mobile Lab for Sale
For Sale - C1D2 certified custom-built mobile extraction lab. Hardly used. $125K.
Tech-2538: Fairly New, Clinical Lab in Georgia
This Lab offers a solid platform for growth. A completely managed Lab that anyone with marketing and management skills can run. Price: $300K.
Tech-2524: Brand New Molecular CLIA Lab in the TN
Validated for Molecular Detection of Pathogens and Covid-19. Debt-free. Can optionally provide customization and complete management. $550K Asking Price.
Tech-2503: Very Profitable, Well-Established Clinical Lab in the South East
The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. 2021 Revenue: $6.8M, EBITDA: $2.6M.
ALL CURRENT LISTINGS
Besides our Featured listings below, see all our current listings by following links below: